Natera Inc
NTRA
Market Cap$16.06B
Close$
$97.68
24.8% downside
Current Fair Value
24.8% downsideOvervalued by 24.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $16.06 Billion |
|---|---|
| Enterprise Value | $15.71 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.78 |
| Beta | 1.53 |
| Outstanding Shares | 122,853,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -54.6 |
|---|---|
| PEG | 82.5 |
| Price to Sales | 11.8 |
| Price to Book Ratio | 21.64 |
| Enterprise Value to Revenue | 11.54 |
| Enterprise Value to EBIT | -50.06 |
| Enterprise Value to Net Income | -54 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.53 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Natera Inc
Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operat...